Just ran on LinkIn the number of people that say they are working on Afrezza. When I ran the numbers on 04/16/2015 there were 34 in the US and 1 in France. Over the last few months the number has gone up a bit, we are at 64 in the US and 3 in France.
If they trained 350 Reps in Vegas in the 3rd QRT it will be interesting to see if the number goes up more.
There is quite a bit of information listed if you read the BIOs. One Rep quoted below said he was ranked number 4 out of 204 Reps in the 2 QRT.
Quote from one of the contract Reds that is working on Afrezza
2015 Sanofi Rankings:
Ranked 1 out of 198 Q1 2015 (Lantus/Afrezza)
Ranked 4 out of 204 Q2 2015 (Toujeo/Afrezza)
There is also other information that I find enlightening,
Senior Diabetes Sales Professional, Sanofi,
August 2013 – Present (2 years 3 months)
Chosen by senior management as one of a select group of reps to pilot launch of Afrezza, an inhaled insulin product; achieved #4 ranking of 19 reps in the region in a highly challenging sales environment.
Specialty Sales Representative at Sanofi
As the Regional Challenger Champion I have played an instrumental role in helping pull through this mindset for over 80 people during the Launch of Afrezza and Toujeo.
Medical Device/Pharmaceutical District Sales Manager
May 2015 – Afrezza (new rapid acting inhaled insulin device) – #1/11 in East Texas Region for new RX’s
Senior Area Business Leader, Sanofi
August 2015 – Present (3 months)
Lead, recruit, hire and train a team of Diabetes and Specialty Sales Professionals in Georgia. Rapidly build and develop a high performing, highly experienced specialty southeast sales team. Responsible for meeting and exceeding sales objectives with distinct specialty brands including Toujeo, Afrezza and Apidra.